MedTrace Logo

Double Blind Comparative Study of TAK-875

NCT01585792 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2013-04-16

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of treatment with TAK-875 in diabetic patients.

Conditions

  • Diabetic Patients

Interventions

DRUG

TAK-875

DRUG

TAK-875

DRUG

Glimepiride

DRUG

Placebo

Sponsors & Collaborators

Study Design

Purpose
TREATMENT

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01585792 on ClinicalTrials.gov